JUL 18, 2016 12:21 PM PDT

Hybrid Lymphocytes Zap Cancer

WRITTEN BY: Kara Marker
For the first time in a human tumor, scientists from the Perelman School of Medicine at the University of Pennsylvania have discovered a “hybrid lymphocyte” - part neutrophil and part antigen-presenting cell. Will learning more about this immune cell lead to a new generation of cancer immunotherapy drugs?

In their study published in Cancer Cell, Pennsylvania scientists aimed to characterize the so-called tumor-associated neutrophil (TAN) that was found at high levels in the microenvironment of tumors in samples of early-stage lung cancer. Neutrophils are normally first-responders to an infection site, killing pathogens by engulfing them and releasing perforating enzymes. Antigen-presenting cells include a variety of different lymphocytes that intercept pathogens and display pieces of them on their cell surface for cells like T lymphocytes to recognize, warning them of an invasion. 
How Cancer Immunity Works | Image: journal.frontiersin.org
During their research, the scientists wanted to know how TANs helped reduce tumor volume. In order to potentially manipulate TAN activity for future immunotherapies, they would need to understand TAN function first. The researchers investigated closely how TAN activity affected the response of cytotoxic T cells, another immune cell type that aggressively targets tumors.

“Our findings demonstrate that the early-stage lung tumor microenvironment can drive neutrophils to differentiate into a cell subset with enhanced anti-tumor capabilities,” explained coauthor of the study Sunil Singhal, MD. “Interestingly, this hybrid population disappears as tumors enlarge.”

In addition to targeting and fighting cancer cells, cytotoxic T cells kill viruses, bacteria, and even protozoa. Cytotoxic T cells cleverly cause death in foreign cells by reprogramming their cellular machinery so they will undergo apoptosis, a process of programmed cell death.

“Perhaps if we can expand the hybrid neutrophils in patients early on, we can augment anti-tumor T cell activity,” suggested senior author of the study Evgeniy B. Eruslanov, PhD. Considering the role of cytotoxic T cells in other pathologies in addition to cancer, therapy using hybrid neutrophils could be useful for multiple diseases in the future. 
 


Sources: University of Pennsylvania School of Medicine, Immunobiology: The Immune System in Health and Disease. 5th edition., PubMed Health, Nature
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate ...
APR 13, 2020
Cannabis Sciences
APR 13, 2020
Smoking Cannabis Increases COVID-19 Risk
Health experts from the National Institute on Drug Abuse and the American Lung Association have said that smoking cannab ...
APR 14, 2020
Immunology
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 15, 2020
Immunology
APR 15, 2020
How Malaria Protects Itself from the Immune System
A specific parasitic species causes the most deaths from malaria: Plasmodium falciparum. This parasite does so by avoidi ...
MAY 14, 2020
Immunology
MAY 14, 2020
Antibody-laden Nanoparticles to Help COVID Patients Breathe Easy
Antibodies are a powerful countermeasure against COVID-19. Not only can they relieve symptoms in patients experiencing s ...
MAY 17, 2020
Coronavirus
MAY 17, 2020
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
Some good news comes as researchers scramble for potential vaccine candidates amidst the global COVID-19 pandemic. Scien ...
Loading Comments...